The interaction between NKG2D, a receptor of NK cells and cytotoxic T lymphocytes (CTLs), and ULBP2 (NKG2D ligand) expressed in tumor cells, allows NK cells to kill the tumor cells. The gene discussed is KLRK1; the disease is neoplasm.